portation.[5] A more fundamental understanding of the vari-
ous processes that are involved in actin dynamics may lead
to a more profound knowledge regarding cell organization,
which might eventually be exploited for pharmaceutical pur-
poses, for example, in cancer therapy.[6] In addition, it has
been shown that the treatment of yeast cells with rhizopodin
results in a dramatically decreased phagocytosis efficiency.[7]
Intrigued by this impressive biological profile, programs
that were directed toward the determination of the absolute
structure of rhizopodin were initiated. During their X-ray
diffraction studies of actin-bound rhizopodin in 2008, in
combination with advanced HRMS analysis, Jansen, Schu-
bert, and co-workers realized that the originally proposed
structure of rhizopodin needed to be revised to a C2-sym-
metric dimer (2, Figure 1).[8] In a parallel study, the full rela-
tive and absolute stereochemistry of rhizopodin was as-
signed by ourselves by exploiting a variety of advanced
NMR spectroscopic methods and molecular modeling, as
well as chemical-derivatization experiments.[9] Simultaneous-
ly, the complete stereochemistry of rhizopodin was inde-
pendently assigned by the group of Schubert.[10]
Altogether, the unique architecture of rhizopodin is char-
acterized by a central 38-membered macrolactone core,
which is comprised of two oxazole rings and two diene units,
together with two stereotetrads adjacent to geminal dimeth-
yl centers. Notably, the relative configuration within this
specific type of hindered subunit appears to be unprecedent-
ed in nature. Attached to the central core are two side
chains with N-vinyl-formamide termini. It became clear
from the X-ray structure of actin-bound rhizopodin that
these side chains were responsible for the formation of
a very stable ternary complex with two G-actin units.
More recently, Pistorius and Mꢁller proposed a biosynthet-
ic pathway to rhizopodin by analyzing the respective gene
clusters that are responsible for the synthesis of rhizopodin
in Stigmatella aurantiaca.[11] Interestingly, they found a trans-
polyketide synthase[12] that was involved in these bacteria,
which meant that all of the methyl branches on the carbon
skeleton must have resulted from methyl-transferase do-
mains, such as in the biosynthesis of bryostatin. By applying
the empirical models that were proposed by McDaniel and
co-workers and Caffrey for the stereochemical outcome of
ketoreductase activity,[13] they found a complete match be-
tween all of the hydroxy-bearing stereocenters and the ini-
tially proposed structure.
The intriguing and synthetically challenging architecture
of rhizopodin, together with its sparse natural supply,
piqued our interest in developing a total synthesis of this un-
precedented dimeric macrolide, not only to enable the un-
ambiguous confirmation of its initially uncertain stereo-
chemistry, but also to support further biological evaluations
and to enable structure–activity studies, as well as the devel-
opment of simplified analogues to further understand and
potentially utilize the unique biological profile of rhizopo-
din.
ments,[14] as well as a preparation of the originally proposed
monomeric structure, had been reported[15] before a first
total synthesis was accomplished by our group.[16] During
the preparation of this manuscript, Paterson and co-workers
described an alternative synthesis of rhizopodin,[17] which
relied on similar synthetic fragments and an endgame strat-
egy that was originally discussed in our total synthesis.[16]
Herein, we report the full details of the various strategies
that we pursued, which eventually culminated in the first
total synthesis of rhizopodin.[18]
Results and Discussion
Retrosynthetic analysis: As shown in Figure 2, our synthetic
approach relied on the late-stage attachment of the side
chains in a bidirectional manner to enable a modular con-
nection of this critical part of the pharmacophore. We plan-
ned to introduce the side chains either through an aldol/
elimination/reduction sequence (i.e., through the coupling
of compound 3 with compound 4)[19] or by applying a HWE
coupling of compound 3 with compound 5 and subsequent
1,4-reduction.
Because we were concerned about the stability of com-
pound 5, we decided to use the OTES group as a synthetic
equivalent of the enamide terminus, in contrast to a fully
elaborate side chain (4). In both cases, macrocyclic dialde-
hyde 3 would serve as the coupling partner.[20] At this point,
we planned to exploit the inherent symmetry in compound 3
and, thus, we dissected both ester motifs, thereby leading to
their respective monomeric fragments (6 and 7). A distinc-
tive structural feature in fragments 6 and 7 is the diene
moiety, which could be forged by means of a suitable cross-
coupling method. Then, ring-closure may either be achieved
by means of a macrolactonization reaction or by employing
a cross-coupling reaction, thereby rendering considerable
flexibility into our synthetic plan. An inspection of these
strategic considerations revealed that four fragments,
namely C1–C7 building blocks 8 and 9 and C8–C22 building
blocks 10 and 11, could be suitable for the assembly of the
macrocyclic core.
As shown in Figure 3, we considered various strategies for
the synthesis of this central building block. To enable
a short route, we intended to form the oxazole ring through
a convergent cyclodehydration sequence, which required
aminoalcohol 13 and an appropriate carboxylic acid as the
key components. Our first approach envisaged a synthesis of
compound 12 with all of the stereocenters between atoms
C16 and C21 already in place before the ring-closure reac-
tion.
As mentioned above, no method for the construction of
the sterically hindered stereotetrad of compound 11 with
the required relative configuration had been reported at the
beginning of our campaign. Therefore, we planned a stepwise
strategy, which relied on an Evans aldol reaction for the
preparation of the C20/C21-syn-relationship, an asymmetric
Sharpless epoxidation to install the stereocenter at the C18
Rhizopodin has attracted considerable synthetic efforts
from various groups and several syntheses of elaborate frag-
15994
ꢃ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2013, 19, 15993 – 16018